What is the effect of clarithromycin dispersible tablets in the treatment of mild pediatric mycoplasma pneumonia?

Clarithromycin dispersible tablets (ice gram) is a prescription drug, developed and produced by Sichuan Wanglintang Pharmaceutical Co., Ltd., which is suitable for the following infections caused by clarithromycin-sensitive bacteria.

1. Nasopharyngeal infection: tonsillitis, pharyngitis, sinusitis.

2. Lower respiratory tract infection: acute bronchitis, acute attack of chronic bronchitis and pneumonia.

3. Skin and soft tissue infections: impetigo, erysipelas, folliculitis, boils and wound infections, etc. There are good results. So what is the effect of clarithromycin dispersible tablets in the treatment of mild pediatric mycoplasma pneumonia?

In recent years, the number of mycoplasma infections in children has gradually increased, and the age of onset is earlier, and the younger the age, the more atypical the clinical manifestations are, and Mycoplasma pneumoniae not only invades the respiratory tract, but also causes multi-system and multi-organ damage, which seriously endangers children's health.It is very important to understand the clinical characteristics of Mycoplasma pediatrica, make a timely diagnosis, and give timely and effective treatment. Because the biological characteristics of mycoplasma are different from those of general pathogenic bacteria, some antimicrobial drugs commonly used in clinical practice, including antibiotics with strong bactericidal effects, are often ineffective in the treatment of mycoplasma infection.

Macrolide antibiotics represented by erythromycin have become the main therapeutic drugs for mycoplasma infection because they can act on the 50S subunit of the ribosomal of the cell and hinder the synthesis of bacterial proteins, and have shown unique efficacy for mycoplasma infection.